Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Van den Bosch

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Clinical Rheumatology|December 4, 2009
A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestationsFilip Van den Bosch
Lancet (London, England)|June 13, 2018
Clinical management of psoriatic arthritisFilip Van den Bosch, Laura Coates
Rheumatology (Oxford, England)|October 20, 2021
IL-23 and axial disease: do they come together?Philip Mease, Filip van den Bosch
International Journal of Rheumatic Diseases|January 30, 2014
Dose optimization of infliximab in patients with rheumatoid arthritisRieke Alten, Filip van den Bosch
Expert Opinion on Emerging Drugs|June 4, 2013
Emerging therapies for rheumatoid arthritisPeggy Jacques, Filip Van den Bosch
Nature Reviews. Rheumatology|November 21, 2012
Spondyloarthritis: A conundrum: classifying patients with SpA in daily practiceFilip Van den Bosch, Dirk Elewaut
Best Practice & Research. Clinical Rheumatology|December 10, 2014
PrefaceAtul Deodhar, Filip van den Bosch
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Treatment of spondyloarthritis beyond TNF-alpha blockadeFilip Van den Bosch, Atul Deodhar
Best Practice & Research. Clinical Rheumatology|December 10, 2014
The concept of spondyloarthritis: where are we now?Neha Garg, Filip van den Bosch, Atul Deodhar
Cytokine|March 7, 2006
Anti-TNF-alpha therapy in ankylosing spondylitisFilip De Keyser, Filip Van den Bosch, Herman Mielants
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Clinical Rheumatology|December 4, 2009
A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestationsFilip Van den Bosch
Lancet (London, England)|June 13, 2018
Clinical management of psoriatic arthritisFilip Van den Bosch, Laura Coates
Rheumatology (Oxford, England)|October 20, 2021
IL-23 and axial disease: do they come together?Philip Mease, Filip van den Bosch
International Journal of Rheumatic Diseases|January 30, 2014
Dose optimization of infliximab in patients with rheumatoid arthritisRieke Alten, Filip van den Bosch
Expert Opinion on Emerging Drugs|June 4, 2013
Emerging therapies for rheumatoid arthritisPeggy Jacques, Filip Van den Bosch
Nature Reviews. Rheumatology|November 21, 2012
Spondyloarthritis: A conundrum: classifying patients with SpA in daily practiceFilip Van den Bosch, Dirk Elewaut
Best Practice & Research. Clinical Rheumatology|December 10, 2014
PrefaceAtul Deodhar, Filip van den Bosch
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Treatment of spondyloarthritis beyond TNF-alpha blockadeFilip Van den Bosch, Atul Deodhar
Best Practice & Research. Clinical Rheumatology|December 10, 2014
The concept of spondyloarthritis: where are we now?Neha Garg, Filip van den Bosch, Atul Deodhar
Cytokine|March 7, 2006
Anti-TNF-alpha therapy in ankylosing spondylitisFilip De Keyser, Filip Van den Bosch, Herman Mielants
Pageof 20